Drug and pharmaceutical recalls
17747 federal recalls on file. Federal recalls for prescription drugs, OTC medications, supplements, and pharmaceuticals. Sourced from the FDA and translated into plain English.
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIPapaverine 40 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIOxytocin 20 units/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IINeomycin / Polymyxin / Dexamethasone Ophthalmic Drops, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IINaproxen 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIMiconazole 3% Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIMICC (Methionine, Inositol, Choline, Cyanocobalamin, Chromium) Inj and MICC 25/50/330 Inj, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIMetoclopramide 5 mg/ml Injection,compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIMethylprednisolone Acetate 80 mg/ml Injection, compounded by Olympia, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIMethylcobalamin 25 mg/ml Inj and 5000 mcg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIMethylcobalamin 1 mg/ml / Folic Acid 2.5 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIMethylcobalamin P 10/ml Creatine 40 mg/ml / Arginine 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIMetabolase Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIMetabolase Forte Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIMeloxicam 5 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIMedroxyprogesterone 150 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIMedetomidine 2 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IILisinopril 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IILipotoxin Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIL-ArGiNINE 200 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIKetoprofen Solution 10% Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIKetamine 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIITPP 50 mg/ml DMG 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIIodine 20 mg Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIIdoxuridine 0.1% Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIHippiron 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIHCG 125iu/0.25ml (550iu/ml), 3500iu and 10,000iu, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIHACC 270.1 Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIGuanabenz 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIGuanabenz 8 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- 2013-07-17FDA-DrugLowlite Investments, Inc. D/B/A Olympia PharmacyClass IIGlutathione 200 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Get notified about new drug recalls
Free weekly digest. We email when a new federal recall in this category — or anything else affecting your household — is published.
Get the Sunday Brief